hydroxychloroquine has been researched along with colchicine in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (8.33) | 18.7374 |
| 1990's | 2 (5.56) | 18.2507 |
| 2000's | 5 (13.89) | 29.6817 |
| 2010's | 11 (30.56) | 24.3611 |
| 2020's | 15 (41.67) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Gall, EP | 1 |
| Habib, GS; Quismorio, FP; Stimmer, MM | 1 |
| Aubé, C; Barré, P; Calès, P; Carpentier, S; Joundy, N; Leclech, C; Oberti, F; Rousselet, MC | 1 |
| BOUMA, HG; DEVRIES, K; JANSZ, A; NIEWEG, HO | 1 |
| Ben-Chetrit, E; Fischel, R; Hinz, B; Levy, M | 1 |
| Kalunian, KC; Terkeltaub, R; Wu, CW | 1 |
| Asial, R; Boente, Mdel C; Happle, R; Nadra, G | 1 |
| Kreuter, JD; Lonesky, TA; Rhodes, CH; Wortmann, RL | 1 |
| Amoura, Z; Barete, S; Benveniste, O; Bourgeois, P; Cacoub, P; Dubourg, O; Francès, C; Gatfossé, M; Lebeaux, D; Maisonobe, T; Piette, JC; Renoux, J; Sène, D; Wechsler, B | 1 |
| Miller, AV; Ranatunga, SK | 1 |
| Cabane, J; Chiche, L; Costedoat-Chalumeau, N; Cottereau, A; De Faucal, P; Graveleau, J; Hachulla, E; Hamidou, M; Hello, M; Lavigne, C; Néel, A; Rondeau-Lutz, M; Seiberras, S; Tournemaine, N | 1 |
| Erten, S; Taskaldiran, I; Yakut, ZI | 1 |
| Lüscher, TF; Ridker, PM | 1 |
| Abasq, C; Aractingi, S; Astudillo, L; Bagot, M; Belenotti, P; Bessis, D; Bigot, A; Bouillet, L; Cordoliani, F; Deroux, A; Doutre, MS; Dupin, N; Ebbo, M; Flageul, B; Frémeaux-Bacchi, V; Godmer, P; Guichard, I; Guillevin, L; Hachulla, E; Héron, E; Jachiet, M; Jeudy, G; Jourde-Chiche, N; Jullien, D; Lavigne, C; Le Quellec, A; Macher, MA; Machet, L; Martel, C; Maurier, F; Melboucy-Belkhir, S; Morice, C; Mouthon, L; Petit, A; Simorre, B; Terrier, B; Zenone, T | 1 |
| Chang, JY; Chen, HM; Wang, YP; Wu, YH | 1 |
| Aydın, F; Basaran, O; Cakar, N; Celikel, BA; Uncu, N | 1 |
| Bagot, M; Bouaziz, JD; Flageul, B; Jachiet, M; Terrier, B | 1 |
| Kiyani, A; Parperis, K | 1 |
| Endo, Y; Furukawa, K; Kawakami, A; Koga, T; Sasaki, D; Umeda, M; Yanagihara, K | 1 |
| Cravedi, P; Degli Antoni, A; Delsante, M; Fiaccadori, E; Gandolfini, I; Maggiore, U; Manenti, L; Peruzzi, L; Riella, LV; Zaza, G | 1 |
| Antonatou, K; Antonopoulos, AS; Hadziyannis, E; Lazaros, G; Lazarou, E; Leontsinis, I; Ritis, K; Simantiris, S; Skendros, P; Tousoulis, D; Vassilopoulos, D; Vlachopoulos, C | 1 |
| Bettiol, A; Di Scala, G; Emmi, G; Mattioli, I; Prisco, D; Silvestri, E; Urban, ML; Vaglio, A | 1 |
| Amital, H; Bragazzi, NL; Chodick, G; Gendelman, O; Watad, A | 1 |
| Airó, P; Andreoli, L; Bertasi, V; Bianchi, M; Bottone, D; Brucato, A; Civelli, P; Colombo, E; Cotelli, MS; Damiolini, E; Franceschini, F; Furloni, R; Galbassini, G; Gatta, D; Ghirardelli, ML; Magri, R; Malamani, P; Mendeni, M; Miclini, M; Molinari, S; Morotti, A; Piantoni, S; Richini, D; Salada, L; Scarsi, M; Tincani, A; Turla, M; Vender, A | 1 |
| Gasparyan, AY; Misra, DP; Zimba, O | 1 |
| Burrage, DR; Koushesh, S; Sofat, N | 1 |
| Hasan, SS; Kow, CS | 1 |
| Eleftheria, K; Eleni, M; Evangelia, M; Evangelos, B; Ioannis, K; Vana, S; Vasilios, V; Vissaria, S | 1 |
| Abeles, SR; Jia, S; Kwon, J; Mehta, SR; Nan, B; Watanabe, JH | 1 |
| Aghamuradov, S; Aliyeva, N; Bektas, M; Bolayirli, M; Can, G; Cevirgen, SB; Dag, A; Gul, A; Hatemi, G; Karacan, I; Ozdogan, H; Oztas, M; Sari, S; Seyahi, E; Ugurlu, S | 1 |
| Ioannidis, JPA | 1 |
| Bruun, JM; Hundahl, MP; Kjolby, M; Kragstrup, TW; Mikkelsen, RR; Rodríguez-Carrio, J; Torp, CK | 1 |
| Elliott, JH; Henry, D; Pearson, SA; Schaffer, AL; Zoega, H | 1 |
11 review(s) available for hydroxychloroquine and colchicine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Hypergammaglobulinemic purpura of Waldenstrom associated with systemic lupus erythematosus: report of a case and review of the literature.
Topics: Adult; Colchicine; Female; gamma-Globulins; Humans; Hydroxychloroquine; Immunoglobulin G; Immunoglobulin M; Lupus Erythematosus, Systemic; Prednisone; Rheumatoid Factor; Skin; Vasculitis; Waldenstrom Macroglobulinemia | 1995 |
Calcium-containing crystals and osteoarthritis: implications for the clinician.
Topics: Antirheumatic Agents; Biomarkers; Calcium; Cartilage, Articular; Colchicine; Glucocorticoids; Gout Suppressants; Humans; Hydroxychloroquine; Osteoarthritis; Severity of Illness Index | 2005 |
Immunotherapies in rheumatologic disorders.
Topics: Abatacept; Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Azathioprine; Certolizumab Pegol; Colchicine; Cyclophosphamide; Cyclosporine; Etanercept; Glucocorticoids; Humans; Hydroxychloroquine; Immunoconjugates; Immunoglobulin Fab Fragments; Immunoglobulin G; Infliximab; Interleukin 1 Receptor Antagonist Protein; Isoxazoles; Leflunomide; Methotrexate; Minocycline; Mycophenolic Acid; Polyethylene Glycols; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Rheumatic Diseases; Rituximab; Sulfasalazine; Tumor Necrosis Factor Inhibitors | 2012 |
Are systemic lupus erythematosus patients carrying MEFV gene less prone to renal involvement? Report of three cases and review of the literature.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Colchicine; Cytoskeletal Proteins; Familial Mediterranean Fever; Female; Heterozygote; Humans; Hydroxychloroquine; Kidney; Kidney Function Tests; Lupus Erythematosus, Systemic; Methylprednisolone; Mutation; Patient Acuity; Pyrin; Treatment Outcome; Tubulin Modulators | 2013 |
Anti-inflammatory therapies for cardiovascular disease.
Topics: Adaptive Immunity; Anti-Inflammatory Agents; Antioxidants; Atherosclerosis; C-Reactive Protein; Carrier Proteins; Cell Adhesion Molecules; Colchicine; Humans; Hydroxychloroquine; Interleukin-1; Interleukin-6; Leukotriene Antagonists; Lipoproteins, HDL; Methotrexate; NLR Family, Pyrin Domain-Containing 3 Protein; Phospholipase A2 Inhibitors; Receptors, Interleukin-1; Serpins; Signal Transduction; Sirtuins; Thrombosis; Tumor Necrosis Factor-alpha; Vaccination | 2014 |
SARS-CoV-2 infection among patients with systemic autoimmune diseases.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Autoimmune Diseases; Betacoronavirus; Colchicine; Coronavirus Infections; COVID-19; Cross-Sectional Studies; Female; Humans; Hydroxychloroquine; Italy; Male; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis.
Topics: Adult; Betacoronavirus; Chemoprevention; Colchicine; Coronavirus Infections; COVID-19; Female; Humans; Hydroxychloroquine; Israel; Male; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2; Treatment Failure | 2020 |
Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates.
Topics: Antirheumatic Agents; Betacoronavirus; Colchicine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Hydroxychloroquine; Methotrexate; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Immunomodulatory Drugs in the Management of SARS-CoV-2.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Colchicine; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Cytokines; Female; Humans; Hydroxychloroquine; Immunomodulation; Janus Kinase Inhibitors; Middle Aged; Pandemics; Pneumonia, Viral; Risk Factors; SARS-CoV-2; Tumor Necrosis Factor-alpha | 2020 |
Immunomodulatory and immunosuppressive therapies in cardiovascular disease and type 2 diabetes mellitus: A bedside-to-bench approach.
Topics: Animals; Antibodies, Monoclonal, Humanized; Cardiovascular Diseases; Colchicine; Diabetes Mellitus, Type 2; Etanercept; Humans; Hydroxychloroquine; Immunomodulating Agents; Immunosuppression Therapy; Immunosuppressive Agents; Inflammation; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Interleukin-1beta; Methotrexate; Sulfasalazine | 2022 |
1 trial(s) available for hydroxychloroquine and colchicine
| Article | Year |
|---|---|
Varied regimens in RA and pseudogout evaluated.
Topics: Aged; Arthritis, Rheumatoid; Chondrocalcinosis; Clinical Trials as Topic; Colchicine; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Male; Middle Aged; Penicillamine | 1980 |
24 other study(ies) available for hydroxychloroquine and colchicine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
The use of drugs in rheumatic diseases.
Topics: Analgesics; Anti-Inflammatory Agents; Aspirin; Aurothioglucose; Chloroquine; Colchicine; Gold Sodium Thiomalate; Humans; Hydroxychloroquine; Penicillamine; Prednisone; Rheumatic Diseases; Salicylates | 1984 |
[Favourable course of a pseudotumoral form of hepatic and splenic sarcoidosis under treatment with hydroxychloroquine and colchicine].
Topics: Antimalarials; Colchicine; Drug Therapy, Combination; Female; Gout Suppressants; Humans; Hydroxychloroquine; Liver Diseases; Middle Aged; Sarcoidosis; Splenic Diseases; Time Factors; Tomography, X-Ray Computed | 1995 |
HAEMATOLOGICAL SIDE-EFFECTS OF SOME ANTI-RHEUMATIC DRUGS.
Topics: Aminopyrine; Antirheumatic Agents; Aspirin; Blood Platelets; Chloroquine; Colchicine; Complement Fixation Tests; Drug Hypersensitivity; Gold; Humans; Hydroxychloroquine; Meprobamate; Phenacetin; Phenylbutazone; Probenecid; Purpura; Purpura, Thrombocytopenic; Quinacrine; Rheumatic Diseases; Splenectomy; Toxicology | 1963 |
The effects of colchicine and hydroxychloroquine on the cyclo-oxygenases COX-1 and COX-2.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Gout Suppressants; Humans; Hydroxychloroquine; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Thromboxane A2 | 2005 |
Pronounced linear calcinosis in a boy with mild dermatomyositis. A further possible example of superimposed segmental manifestation of a polygenic disorder.
Topics: Biopsy, Needle; Calcinosis; Child; Colchicine; Dermatomyositis; Disease Progression; Drug Therapy, Combination; Follow-Up Studies; Genetic Predisposition to Disease; Humans; Hydroxychloroquine; Immunohistochemistry; Male; Risk Assessment; Severity of Illness Index; Skin Diseases, Genetic; Treatment Outcome | 2009 |
Hydroxychloroquine and colchicine induced myopathy.
Topics: Aged; Colchicine; Female; Humans; Hydroxychloroquine; Muscular Diseases | 2009 |
Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients.
Topics: Adult; Aged; Antirheumatic Agents; Azathioprine; Colchicine; Drug Therapy, Combination; Eosinophilia; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Middle Aged; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Scleroderma, Localized; Synovitis; Treatment Outcome | 2012 |
Long-term outcome in idiopathic granulomatous mastitis: a western multicentre study.
Topics: Adult; Colchicine; Drug Utilization; Female; Glucocorticoids; Granulomatous Mastitis; Humans; Hydroxychloroquine; Middle Aged; Prognosis; Recurrence; Retrospective Studies; Treatment Outcome | 2013 |
The clinical spectrum and therapeutic management of hypocomplementemic urticarial vasculitis: data from a French nationwide study of fifty-seven patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Colchicine; Comorbidity; Complement C1q; Female; France; Humans; Hydroxychloroquine; Immunologic Deficiency Syndromes; Immunosuppressive Agents; Male; Middle Aged; Retrospective Studies; Skin; Treatment Outcome; Urticaria; Vasculitis; Young Adult | 2015 |
Pyostomatitis vegetans: An oral manifestation of inflammatory bowel disease.
Topics: Adult; Colchicine; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Inflammatory Bowel Diseases; Mouth Mucosa; Prednisolone; Stomatitis | 2015 |
Coexistence of systemic lupus erythematosus and familial Mediterranean fever in a pediatric patient.
Topics: Adolescent; Colchicine; Cyclophosphamide; Familial Mediterranean Fever; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Lupus Nephritis; Mutation; Prednisolone; Pyrin; Treatment Outcome | 2016 |
[Hypocomplementemic urticarial vasculitis].
Topics: Colchicine; Complement C1q; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Male; Urticaria; Vasculitis | 2018 |
Familial Mediterranean Fever Imitating Lupus Flare: A Rare Coexistence of an Autoimmune Disease With an Autoinflammatory Disease.
Topics: Adult; Antirheumatic Agents; Colchicine; Familial Mediterranean Fever; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Mutation; Mycophenolic Acid; Prednisone; Pyrin; Treatment Outcome; Tubulin Modulators | 2018 |
Successful hydroxychloroquine treatment for familial Mediterranean fever in a Japanese patient with concurrent systemic lupus erythematosus.
Topics: Adult; Antirheumatic Agents; Asian People; Colchicine; Cytokines; Familial Mediterranean Fever; Female; Gastrointestinal Diseases; Humans; Hydroxychloroquine; Japan; Lupus Erythematosus, Systemic; Treatment Outcome; Tubulin Modulators | 2020 |
COVID-19 in kidney transplant recipients.
Topics: Aged; Betacoronavirus; Cobicistat; Colchicine; Coronavirus Infections; COVID-19; Cytokines; Darunavir; Drug Combinations; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lopinavir; Male; Middle Aged; Mycophenolic Acid; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Tacrolimus; Transplant Recipients; Treatment Outcome | 2020 |
Hydroxychloroquine for colchicine-resistant glucocorticoid-dependent idiopathic recurrent pericarditis: A pilot observational prospective study.
Topics: Colchicine; Glucocorticoids; Humans; Hydroxychloroquine; Pericarditis; Prospective Studies; Recurrence; Treatment Outcome | 2020 |
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Case-Control Studies; Cohort Studies; Colchicine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Drug Combinations; Enzyme Inhibitors; Female; Hospitalization; Humans; Hydroxychloroquine; Italy; Lopinavir; Male; Middle Aged; Pandemics; Pneumonia, Viral; Proof of Concept Study; Proportional Hazards Models; Respiratory Distress Syndrome; Ritonavir; SARS-CoV-2; Survival Rate | 2020 |
Colchicine as an adjunct to heparin for prophylaxis of venous thromboembolism in patients with COVID-19.
Topics: Anticoagulants; Colchicine; COVID-19 Drug Treatment; Heparin; Humans; Hydroxychloroquine; Methotrexate; Pharmaceutical Preparations; SARS-CoV-2; Venous Thromboembolism | 2021 |
Clinical features and outcomes of hospitalized COVID-19 patients in a low burden region.
Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Adult; Aged; Alanine; Anti-Bacterial Agents; Antimalarials; Antiviral Agents; Azithromycin; Colchicine; COVID-19; Drug Therapy, Combination; Female; Greece; Hospitalization; Humans; Hydroxychloroquine; Male; Middle Aged; Retrospective Studies; SARS-CoV-2; Treatment Outcome; Young Adult | 2021 |
Medication Use Patterns in Hospitalized Patients With COVID-19 in California During the Pandemic.
Topics: Adenosine Monophosphate; Adult; Alanine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anticoagulants; Antiviral Agents; Azithromycin; California; Colchicine; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Drug Therapy, Combination; Drug Utilization Review; Female; Hospitalization; Humans; Hydrocortisone; Hydroxychloroquine; Male; Pandemics; SARS-CoV-2 | 2021 |
Frequency and severity of COVID-19 in patients with various rheumatic diseases treated regularly with colchicine or hydroxychloroquine.
Topics: Colchicine; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Immunoglobulin G; Rheumatic Diseases; SARS-CoV-2 | 2022 |
High-cited favorable studies for COVID-19 treatments ineffective in large trials.
Topics: Azithromycin; Colchicine; COVID-19 Drug Treatment; COVID-19 Serotherapy; Humans; Hydroxychloroquine; Interferons; Lopinavir; Ritonavir | 2022 |
Changes in dispensing of medicines proposed for re-purposing in the first year of the COVID-19 pandemic in Australia.
Topics: Azithromycin; Calcitriol; Colchicine; COVID-19; COVID-19 Drug Treatment; Cross-Sectional Studies; Humans; Hydroxychloroquine; Ivermectin; Pandemics | 2022 |